SIMAP

SIMAP will develop a simulation model of the cancer related MAP-kinase pathway, integrating and analyzing data from various types of resources, which may assist in the development of better cancer treatment.

The completion of the human genome gave hope for a new age of medical understanding, but 4-5 years later costs of drug development are still rising and the success rate has not improved. Drugs that have already hit the market are found to have major side effects not perceived in the past and are often given to patients without discrimination on their likeliness to respond.

Large scale methodologies that thrive in recent years, allowed the industry and academia to gather more information on RNAs and proteins. However, the understanding of the molecular and cellular processes is still lacking, not to mention the connection to the clinical outcome. In order to fully use this data, a comprehensive integration and modelling effort is needed. A systematic rational hypothesis-driven research approach connecting all those levels of information is a much needed computational tool. This is the main goal of SIMAP project.

The ultimate goal of SIMAP is to develop a comprehensive simulation biochemical model of EGFRMAP kinase pathway in connection to cancer clinical information. SIMAP will:

  • Incorporate low-level biochemical modelling of individual molecules;
  • Simulate the behaviour of the pathway;
  • Add genomic and proteomic data;
  • Incorporate individual patients’ responses; and
  • Analyze sub population of responses in the context of the biochemical behaviour and genotype data

For further information, please visit:
http://www.simap-project.org

Project co-ordinator:
Compugen Ltd.

Partners:

  • Aureus Pharma, (FR)
  • Compugen Ltd., (IL)
  • Consejo Superior de Investigaciones Científicas, (ES)
  • Halevi Dweck & Co.Arttic Israel Company Ltd., (IL)
  • Fundacio Institut De Recerca De L'Hospital Universitari Vall D'Hebron, (ES)
  • Fondazione IRCCS Istituto Nazionale Dei Tumori, (IT)
  • The Max-Planck Institute for Infection Biology, (DE)
  • The University of Glasgow, (UK)
  • The Weizmann Institute of Science, (IL)

Timetable: from 01/06 – to 12/08

Total cost: € 4.464.201

EC funding: € 3.126.662

Instrument: STREP

Project Identifier: IST-2004-027265

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Top 20 Breaking eHealth News of 2018

eHealthNews.eu proudly presents the top 20 most popular breaking eHealth news from 2018. Have a wonderful 2019 New(s) Year filled with health, happiness, and spectacular success!

Artificial Intelligence Advances Threate…

Advances in artificial intelligence have created new threats to the privacy of people's health data, a new University of California, Berkeley, study shows. Led by UC Berkeley engineer Anil Aswani...

Shaping Cloud Selects Highland Marketing…

Public sector cloud transformation specialists Shaping Cloud have chosen Highland Marketing as their marketing and PR partner to help them deliver their growth ambitions in the burgeoning health and care...

Rewired Pitchfest Launched to Showcase B…

Digital health innovators and start-ups are invited to pitch their disruptive ideas and prototypes to NHS digital leaders and leading healthtech investors at the new Digital Health Rewired event next...

Allscripts Joins with Microsoft to Explo…

Today, Allscripts (NASDAQ:MDRX), a global leader in health care information technology, announced a collaboration with Microsoft focused on implementing an innovative, integrated model for clinical research, aiming to enhance clinical...

Merck Welcomes Ten New Startups to its I…

Merck, a leading science and technology company, today announced the ten startups that will be joining the seventh intake of its Accelerator program at the Merck Innovation Center in Darmstadt...

First Smartphone App to Detect Opioid Ov…

At least 115 people die every day in the U.S. after overdosing on opioids, according to the National Institute on Drug Abuse. And in 2016, illegal injectable opioids became the...

Stanford Researchers Create a Wireless, …

A new device developed by Stanford University researchers could make it easier for doctors to monitor the success of blood vessel surgery. The sensor, detailed in a paper published Jan...

AI Approach Outperformed Human Experts i…

A research team led by investigators from the National Institutes of Health and Global Good has developed a computer algorithm that can analyze digital images of a woman's cervix and...

Digital Health Consultancy Invests in Cy…

Digital health consultancy Populo Consulting has secured Cyber Essentials Plus certification, in a move that demonstrates its commitment to operating to the same high standards as its NHS clients. Cyber Essentials...

Boehringer Ingelheim Initiates a Collabo…

Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials. Science 37...